About
Basic Data Updated:
10 days agoNovartis India Limited is known for its provision of pharmaceuticals, generics, OTC, and animal healthcare products. The portfolio of prescription medicines is offered through healthcare professionals in the pharmaceuticals segment. In addition, the company also caters to various therapeutic areas such as anti-TB, anti-histamines, cardiovascular, and anti-diabetes through its retail generic products in the generic segment. The animal health segment is primarily focused on cattle and poultry. The OTC segment, on the other hand, operates in the market segments of vitamins, minerals, nutritional, cough, cold, and allergy. Some of the well-known brands in this segment include Otrivin, Calcium Sandoz Lemon, and T-minic. In the animal health segment, the company's products include Tiamutin, San... Read More
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Products or Services related to Novartis India Limited
Financials of Novartis India Limited
Enhance accessibility to Novartis India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Novartis India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Novartis India Limited
Unlock and access historical data on people associated with Novartis India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
NM
Nikhil Malpani Company SecretaryAppointment Date: 27-Apr-2022
Status: Current
SJ
Shilpa Joshi CFOAppointment Date: 01-May-2022
Status: Current
SM
Sanjay Murdeshwar Managing DirectorAppointment Date: 15-Jun-2019
Status: Current
Board Members(4)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Grindlays Bank Creation Date: 21 Jul 1993 | ₹45.00 Cr | Open |
The Industrial Credit And Investment Corpn. Of India Ltd. Creation Date: 13 Feb 1992 | ₹10.00 Cr | Open |
The Industrial Credit And Investment Corpn. Of India Ltd. Creation Date: 13 Feb 1992 | ₹10.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novartis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novartis India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Novartis Comprehensive Leprosy Care Association
Active 30 years 30 daysShilpa Joshi is a mutual person
Franklin Templeton Trustee Services Private Limited
Active 28 years 4 monthsSandra Martyres is a mutual person
Recent activity within the organization
Annual General Meeting
Novartis India Limited last Annual general meeting of members was held on 28 Jul 2023 as per latest MCA records.
28 Jul 2023Balance Sheet
Novartis India Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge registered on 12 Apr 1999 via Charge ID 90232124 with Bnp Paribas was fully satisfied on 10 May 2022.
10 May 2022Director Appointment
Sanker Parameswaran was appointed as a Director was appointed as a Director on 22 Jun 2020 & has been associated with this company since 3 years 10 months .
22 Jun 2020Director Appointment
Sanjay Prabhakar Murdeshwar was appointed as a Managing Director was appointed as a Managing Director on 15 Jun 2019 & has been associated with this company since 4 years 10 months .
15 Jun 2019
Recent News, Updates & Announcement
- After GSK and Novartis handoffs Laeknas drug fails ovarian cancer trial.
Fierce Biotech 30 Jan 2024
- Incyte vets with phase 1 within reach raise 102M for new biotech to create better PARP PI3K drugs.
Fierce Biotech 24 Jan 2024
- JB Pharmaceuticals acquisition of a portfolio of ophthalmology drugs from Novartis.
Trilegal 10 Jan 2024
- Semma Therapeutics Raises 114 Million Series B Financing.
Business Wire 30 Nov 2017
- Indias Samara acquires drug portfolio from Novartis.
Asian Venture Capital Journal 11 Oct 2017
Frequently asked questions
What is the Incorporation or founding date of Novartis India Limited?